Literature DB >> 28331731

Metaplastic Breast Cancer.

Halil Türkan1, M Şehsuvar Gökgöz1, N Serhat Parlak1.   

Abstract

Metaplastic Breast Cancer (MBC) is a term referring to a heterogeneous group with malignant epithelial and mesenchymal tissue components. MBC is a rare disease, accounting for 0.2% of all breast cancers. Most MBC are triple negative cancers with poor prognosis and an aggressive clinical course. Herein, we aimed to present a 74-year-old patient with metaplastic breast cancer along with clinical, radiologic and pathologic properties.

Entities:  

Keywords:  Metaplastic Breast Cancer; malignant epithelial tumor; mesenchymal tumor

Year:  2016        PMID： 28331731      PMCID： PMC5351435          DOI： 10.5152/tjbh.2015.2505

Source DB:  PubMed          Journal:  J Breast Health        ISSN： 1306-0945


  12 in total

1.  Metaplastic breast carcinoma. Rare form of mammary cancer.

Authors:  A G Huvos; J C Lucas; F W Foote
Journal:  N Y State J Med       Date:  1973-05-01

2.  Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation.

Authors:  Işil Günhan-Bilgen; Ayşenur Memiş; Esin Emin Ustün; Osman Zekioglu; Necmettin Ozdemir
Journal:  AJR Am J Roentgenol       Date:  2002-06       Impact factor: 3.959

Review 3.  Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.

Authors:  Alberto Luini; Marisel Aguilar; Giovanna Gatti; Roberta Fasani; Edoardo Botteri; Jack Antonio Diaz Brito; Patrick Maisonneuve; Anna Rita Vento; Giuseppe Viale
Journal:  Breast Cancer Res Treat       Date:  2006-09-29       Impact factor: 4.872

4.  Metaplastic breast cancer: prognosis and response to systemic therapy.

Authors:  D Rayson; A A Adjei; V J Suman; L E Wold; J N Ingle
Journal:  Ann Oncol       Date:  1999-04       Impact factor: 32.976

5.  Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma.

Authors:  E S Wargotz; H J Norris
Journal:  Hum Pathol       Date:  1989-07       Impact factor: 3.466

6.  Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Authors:  Mark R Carter; Jason L Hornick; Susan Lester; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2006-03       Impact factor: 6.394

7.  AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.

Authors:  Stephanie M Sitterding; William R Wiseman; Carol L Schiller; Chunyan Luan; Feng Chen; Jose V Moyano; William G Watkin; Elizabeth L Wiley; Vincent L Cryns; Leslie K Diaz
Journal:  Ann Diagn Pathol       Date:  2007-10-24       Impact factor: 2.090

Review 8.  Metaplastic carcinoma of the breast: Treatment, results and prognostic factors based on international literature.

Authors:  Alessandro Sanguinetti; Roberta Lucchini; Stefano Santoprete; Raffaele Farabi; Lorella Fioriti; Giovanni Bistoni; Roberta Triola; Nicola Avenia
Journal:  Ann Ital Chir       Date:  2014 Mar-Apr       Impact factor: 0.766

9.  Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors.

Authors:  Adher D Al Sayed; Amr N El Weshi; Asma M Tulbah; Mohamed M Rahal; Adnan A Ezzat
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

10.  Biphasic metaplastic sarcomatoid carcinoma of the breast.

Authors:  B T Hennessy; S Giordano; K Broglio; Z Duan; J Trent; T A Buchholz; G Babiera; G N Hortobagyi; V Valero
Journal:  Ann Oncol       Date:  2006-02-09       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.